Achieving control of resistant hypertension: Not just the number of blood pressure medications

doi:10.5494/wjh.v9.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10617)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

571

WORD

315

HTML

7314

Figures (1-2)

348

Tables (1-2)

308

Sum=8856

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

838

Download

923

Sum=1761

Mar 12, 2019 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hypertension

ISSN

2220-3168

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hypertens. Mar 12, 2019; 9(1): 1-16
Published online Mar 12, 2019. doi: 10.5494/wjh.v9.i1.1

Full Size Figure Download Figure

Figure 2 Therapeutic targets in resistant hypertension. ¹Step one and step two are part of guidelines and apply to all patients. Step Three involving device-based modalities is still being studied, and is not yet recommended or in widespread clinical use. RAAS: Renin Angiotensin Aldosterone System; ACEi: Angiotensin converting enzyme inhibitor; ARB: Angiotensin II receptor blocker.

Citation: Schmidt K, Kelley W, Tringali S, Huang J. Achieving control of resistant hypertension: Not just the number of blood pressure medications. World J Hypertens 2019; 9(1): 1-16
URL: https://www.wjgnet.com/2220-3168/full/v9/i1/1.htm
DOI: https://dx.doi.org/10.5494/wjh.v9.i1.1